Abstract
Niemann–Pick disease (NPD) types A and B are autosomal recessive disorders caused by acid sphingomyelinase (ASM) deficiency due to mutation in the sphingomyelin phosphodiesterase 1 gene (SMPD1). Although a number of SMPD1 mutations were reported, expression studies were performed for only a small number of missense mutations. We evaluated three unrelated patients with clinical manifestations of NPD. Sequence analysis revealed two previously described (S248R and W391G) and two novel (G247D and F572L) missense mutations. To analyze the effects of the novel mutations on ASM function, cDNA was generated by site-directed mutagenesis and expressed in COS-7 cells. In vitro biochemical assays revealed marked deficiency of ASM activity consistent with the disease phenotype in cells homoallelic for each mutation. We show that each mutation dramatically reduced half-life and catalytic activity of ASM with more pronounced decrease by the G247D mutation. These data suggest that impaired protein stability and decreased enzyme activity are responsible for the disease in sphingomyelinase-deficient patients carrying the G247D and F572L mutations.
Competing interests: None declared.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Da Veiga PL, Desnick RJ, Adler DA, Disteche CM, Schuchman EH (1991) Regional assignment of the human acid sphingomyelinase gene (SMPD1) by PCR analysis of somatic cell hybrids and in situ hybridization to 11p15.1-15.4. Genomics 9:229–234
Dardis A, Zampieri S, Filocamo M, Burlina A, Bembi B, Pittis MG (2005) Functional in vitro characterization of 14 SMPD1 mutations identified in Italian patients affected by Niemann–Pick type B disease. Hum Mutat 26:164, in Brief
Desnick JP, Kim J, He X, Wasserstein MP, Simonaro CM, Schuchman EH (2010) Identification and characterization of eight novel SMPD1 mutations causing types A and B Niemann-Pick disease. Mol Med 16:316–321
Erdős M, Uzvölgyi E, Nemes Z et al (2005) Characterization of a disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease. Hum Mutat 25:506, in Brief
Ferlinz K, Hurwitz R, Moczall H, Lansmann S, Schuchman EH, Sandhoff K (1997) Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis. Eur J Biochem 243:511–517
Harzer K, Rolfs A, Bauer P et al (2003) Niemann-Pick disease types A and B are clinically but also enzimatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292K. Neuropediatrics 34:301–306
Jiao H, Tóth B, Erdős M et al (2008) Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol 46:202–206
Mihaylova V, Hantke J, Sinigerska et al (2007) Highly variable neural involvement in sphingomyelinase-deficient Niemann-Pick disease caused by ancestral Gypsy mutation. Brain 130:1050–1061
Pavlu-Pereira H, Asfaw B, Poupctova H et al (2005) Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis 28:203–227
Rodríguez-Pascau L, Gort L, Schuchman EH, Vilageliu L, Grinberg D, Chabás A (2009) Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients. Hum Mutat 30:1117–1122
Schuchman EH (2007) The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J Inherit Metab Dis 30:653–663
Schuchman EH, Desnick RJ (2001) Niemann-Pick disease type A and B: acid sphingomyelinase deficiencies. In: Scriver CR, Beaudet AL, Sly WS, Childs B, Valle D, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3589–3610
Sikora J, Pavlu-Pereira H, Elleder M, Roelofs H, Wevers RA (2003) Seven novel acid sphingomyelinase gene mutations in Niemann-Pick type A and B patients. Ann Hum Genet 67:63–70
Simonaro CM, Desnick RJ, McGovern MM, Wasserstein MP, Schuchman EH (2002) The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype/phenotype correlations. Am J Hum Genet 71:1413–1419
Tóth B, Wolff AS, Halász Z et al (2010) Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy. Clin Endocrinol (Oxf) 72:641–647
Wasserstein MP, Aron A, Brodie SE, Simonaro C, Desnick RJ, McGovern MM (2006) Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease. J Pediatr 149:554–559
Acknowledgments
We thank the parents of the patients for helpful collaboration. This work was supported by TÁMOP 4.2.1./B-09/1/KONV-2010-0007 and TÁMOP 4.2.2-08/1-2008-0015 grants to L.M.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Gregory M. Pastores.
Electronic Supplementary material
Rights and permissions
Copyright information
© 2011 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tóth, B. et al. (2011). Molecular Genetic Characterization of Novel Sphingomyelin Phosphodiesterase 1 Mutations Causing Niemann–Pick Disease. In: JIMD Reports - Case and Research Reports, 2011/3. JIMD Reports, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2011_80
Download citation
DOI: https://doi.org/10.1007/8904_2011_80
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24935-8
Online ISBN: 978-3-642-24936-5
eBook Packages: MedicineMedicine (R0)